Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00229983 · ClinicalTrials.gov registry record · Phase 2

Medical Office Intervention for Adolescent Drug Use

A Phase 2 study, sponsored by Boston Children's Hospital.

Completed
Registry status
Phase 2
Development phase
170
Enrollment target

NCT00229983 is a Phase 2 study that has completed, run by Boston Children's Hospital. The registered enrollment target is 170 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00229983, a Phase 2 study, has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
Phase 2
Development phase
170 participants
Enrollment target

Study Summary

The goal of this study is to assess the efficacy of a new intervention based on motivational enhancement therapy among adolescents with a history of substance use.

Interventions

  • BEHAVIORAL Motivational Enhancement Therapy

Trial Details

FieldValue
Enrollment Target 170 participants
Start Date 2004-06
Est. Completion 2010-05
Phase Phase 2

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT00229983

The ClinicalTrials.gov registry entry for NCT00229983 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Motivational Enhancement Therapy is the first listed.

NCT00229983 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00229983 about?

NCT00229983 is a clinical study titled "Medical Office Intervention for Adolescent Drug Use". The goal of this study is to assess the efficacy of a new intervention based on motivational enhancement therapy among adolescents with a history of substance use.

What is the current status of trial NCT00229983?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 170 participants. The study started on 2004-06. Estimated completion is 2010-05.

What interventions are being tested in trial NCT00229983?

The interventions under investigation include: Motivational Enhancement Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00229983?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.